Glenmark Pharmaceuticals Limited (GLENMARK) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹2,671.1 (+2.94% day change)
Key ratios
- P/E ratio
- 55.35
- P/B ratio
- 5.72
- ROE (%)
- 12.96
- ROCE (%)
- 29.55
- Debt/Equity
- 0.06
- Dividend yield (%)
- 0.23
- Market cap (₹ Cr)
- 75,385.03
Forensic checks
Piotroski F-Score: 7/9 · Altman Z-Score: 9.02 · Beneish M-Score: -2.56
InvestSights quality score
74.1/100 — Above Average (descriptive data-driven composite; not a recommendation)
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.